Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inhibitor Therapeutics, Inc.INTI · Entity 7783 | Director | December 22, 2020 | December 28, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inhibitor Therapeutics, Inc.
Report date December 22, 2020 · Filed December 28, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.03 · Expires 2030-12-22 | Direct | 580,646 |
Reported balance
After 2020-12-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-12-22 · Grant · Acquired 580,646 · Balance 580,646 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2020 Filed Dec 28, 2020 21:30 UTC | Inhibitor Therapeutics, Inc. INTI · Entity 7783 | GrantCommon Stock Option · Derivative | 580,646 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0000899243-20-035200 · doc4.xml · derivative · entry 1 Peattie Debra · CIK 0001792108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,646 Underlying: Common Stock · 580,646 shares Expires 2030-12-22 Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 13:01 UTC | Inhibitor Therapeutics, Inc. INTI · Entity 7783 | GrantCommon Stock Option · Derivative | 1,000,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-20-009310 · doc4.xml · derivative · entry 1 Peattie Debra · CIK 0001792108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2030-03-20 Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 21:32 UTC | Inhibitor Therapeutics, Inc. INTI · Entity 7783 | GrantCommon Stock Option · Derivative | 210,000 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0000899243-19-029254 · doc4.xml · derivative · entry 1 Peattie Debra · CIK 0001792108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 210,000 shares Expires 2029-12-12 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.